Scynexis (SCYX) Enterprise Value (2013 - 2026)
Scynexis' (SCYX) quarterly Enterprise Value came in at -$36.8 million in Q1 2026, up 32.24% YoY from -$27.8 million in Q1 2025, and down 72.22% on a QoQ basis from -$21.3 million in Q4 2025.
Scynexis (SCYX) Enterprise Value (2013 - 2026) Analysis & Trends
Scynexis (SCYX) has 14 years of Enterprise Value data on file, last reported at -$36.8 million in Q1 2026.
- Quarterly Enterprise Value rose 32.24% year-over-year to -$36.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$36.8 million (up 32.24% YoY) and the FY2025 annual result came in at -$21.3 million, down 29.44% from the prior year.
- Enterprise Value retreated to -$36.8 million in Q1 2026, from -$21.3 million in the prior quarter.
- In the past five years, Enterprise Value ranged from a high of -$16.5 million in Q4 2024 to a low of -$130.7 million in Q2 2024.
- A 5-year average of -$59.8 million and a median of -$44.8 million in 2025 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2023 — Enterprise Value slumped 53.74% — and 2024, when it jumped 72.38%.
- Tracing SCYX's Enterprise Value over 5 years: stood at -$73.5 million in 2022, then jumped by 53.16% to -$34.4 million in 2023, then surged by 52.12% to -$16.5 million in 2024, then declined by 29.44% to -$21.3 million in 2025, then slumped by 72.22% to -$36.8 million in 2026.
- The last three Enterprise Value figures came in at -$36.8 million (Q1 2026), -$21.3 million (Q4 2025), and -$38.0 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -882.82 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -3.65 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -1.68 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -5.79 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -2.66 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -886.50 Mn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -389.80 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | -530.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | -164.00 Mn |
| 10 | Scynexis | 61.37 Mn | -53.33 Mn | - | -114.70 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -114.70 Mn |
| Mar 31, 2026 | -36.75 Mn |
| Dec 31, 2025 | -21.34 Mn |
| Sep 30, 2025 | -37.98 Mn |
| Jun 30, 2025 | -44.79 Mn |
| Mar 31, 2025 | -54.24 Mn |
| Dec 31, 2024 | -16.49 Mn |
| Sep 30, 2024 | -29.17 Mn |
| Jun 30, 2024 | -130.74 Mn |
| Mar 31, 2024 | -35.86 Mn |
| Dec 31, 2023 | -34.43 Mn |
| Sep 30, 2023 | -105.58 Mn |
| Jun 30, 2023 | -85.54 Mn |
| Mar 31, 2023 | -26.97 Mn |
| Dec 31, 2022 | -73.50 Mn |
| Sep 30, 2022 | -68.68 Mn |
| Jun 30, 2022 | -118.70 Mn |
| Mar 31, 2022 | -95.21 Mn |
| Dec 31, 2021 | -104.48 Mn |
| Sep 30, 2021 | -100.11 Mn |